236 filings
Page 5 of 12
8-K
a30u3xhuq5
8 Jan 20
Entry into a Material Definitive Agreement
2:26pm
CORRESP
vjdgi2 46pjzw7vz6v6
23 Dec 19
Correspondence with SEC
12:00am
8-K
wd1fgpl3qhz0
17 Dec 19
Entry into a Material Definitive Agreement
12:00am
424B5
97jri8bzq894zaw
17 Dec 19
Prospectus supplement for primary offering
12:00am
UPLOAD
7jq6fw 4cl2r6j5
25 Nov 19
Letter from SEC
12:00am
CORRESP
hcrq 6bl5y
29 Oct 19
Correspondence with SEC
12:00am
UPLOAD
4jibwnk6t4rneenp1tz
23 Oct 19
Letter from SEC
12:00am
8-K
dzcyhuiay
9 Jul 19
Axim® Biotechnologies Signs Licensing Agreement with Leading Gum Distributor to Expand Nutraceutical Division
3:39pm
8-K
am014g
4 Jun 19
AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis
12:00am
8-K
y97a8
23 Apr 19
AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum
4:58pm
8-K
mg3w0v
4 Apr 19
AXIM® Biotechnologies, Inc. Appoints Mauricio Javier Gatto-Bellora to Company’s Board of Directors
12:07pm
NT 10-K
9zd2jq0wlxpp59tvg8r
29 Mar 19
Notice of late annual filing
8:18pm
8-K
xenn85wr
26 Feb 19
Changes in Control of Registrant
3:29pm
8-K
bcng8hetdne4h ale
15 Jan 19
Regulation FD Disclosure
11:25am
8-K
f9thskhmnc8vkmzp477
8 Jan 19
Axim® Biotechnologies Appoints New Chief Executive Officer
10:16am